Table of Contents
ISRN Anesthesiology
Volume 2012, Article ID 970795, 7 pages
http://dx.doi.org/10.5402/2012/970795
Research Article

Isoflurane Enhances the Moonlighting Activity of GAPDH: Implications for GABAA Receptor Trafficking

1Department of Anesthesiology, University of Missouri-Kansas City/Saint Luke’s Hospital, 4401 Wornall Road, Kansas City, MO 64111, USA
2Department of Biochemistry, Kansas City University of Medicine and Biosciences, 1750 Independence Avenue, Kansas City, MO 64106, USA

Received 10 September 2012; Accepted 26 September 2012

Academic Editors: K. Higa and C.-T. Wu

Copyright © 2012 Andrew J. Montalbano et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. J. Laschet, F. Minier, I. Kurcewicz et al., “Glyceraldehyde-3-phosphate dehydrogenase is a GABAA receptor kinase linking glycolysis to neuronal inhibition,” Journal of Neuroscience, vol. 24, no. 35, pp. 7614–7622, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. N. W. Seidler, “Multiple binding partners,” Advances in Experimental Medicine and Biology, vol. 985, pp. 249–267, 2013. View at Google Scholar
  3. A. E. Pattin, S. Ochs, C. S. Theisen, E. E. Fibuch, and N. W. Seidler, “Isoflurane's effect on interfacial dynamics in GAPDH influences methylglyoxal reactivity,” Archives of Biochemistry and Biophysics, vol. 498, no. 1, pp. 7–12, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. T. A. Swearengin, E. E. Fibuch, and N. W. Seidler, “Sevoflurane modulates the activity of glyceraldehyde 3-phosphate dehydrogenase,” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 21, no. 5, pp. 575–579, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. D. M. Laverty and O. Fennema, “Effects of anesthetics and dichlorodifluoromethane on the activities of glyceraldehyde-phosphate dehydrogenase and pectin methylesterase,” Biochemical Pharmacology, vol. 34, no. 16, pp. 2839–2846, 1985. View at Publisher · View at Google Scholar · View at Scopus
  6. D. M. Laverty and O. Fennema, “Effect of anaesthetics and dichlorodifluoromethane on the viability of the cells of Escherichia coli and the activities of some of its enzymes,” Microbios, vol. 44, no. 177, pp. 7–20, 1985. View at Google Scholar · View at Scopus
  7. N. W. Seidler, “Functional diversity,” Advances in Experimental Medicine and Biology, vol. 985, pp. 103–147, 2013. View at Google Scholar
  8. N. W. Seidler, “Compartmentation of GAPDH,” Advances in Experimental Medicine and Biology, vol. 985, pp. 61–101, 2013. View at Google Scholar
  9. M. Kaneda, K. I. Takeuchi, K. Inoue, and M. Umeda, “Localization of the phosphatidylserine-binding site of glyceraldehyde-3-phosphate dehydrogenase responsible for membrane fusion,” Journal of Biochemistry, vol. 122, no. 6, pp. 1233–1240, 1997. View at Google Scholar · View at Scopus
  10. P. E. Glaser, “Rapid plasmenylethanolamine-selective fusion of membrane bilayers catalyzed by an isoform of glyceraldehyde-3-phosphate dehydrogenase: discrimination between glycolytic and fusogenic roles of individual isoforms,” Biochemistry, vol. 34, no. 38, pp. 12193–12203, 1995. View at Google Scholar · View at Scopus
  11. R. J. Hessler, R. A. Blackwood, T. G. Brock, J. W. Francis, D. M. Harsh, and J. E. Smolen, “Identification of glyceraldehyde-3-phosphate dehydrogenase as a Ca2+- dependent fusogen in human neutrophil cytosol,” Journal of Leukocyte Biology, vol. 63, no. 3, pp. 331–336, 1998. View at Google Scholar · View at Scopus
  12. T. Nakagawa, Y. Hirano, A. Inomata et al., “Participation of a fusogenic protein, glyceraldehyde-3-phosphate dehydrogenase, in nuclear membrane assembly,” Journal of Biological Chemistry, vol. 278, no. 22, pp. 20395–20404, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. T. C. Jacob, S. J. Moss, and R. Jurd, “GABAA receptor trafficking and its role in the dynamic modulation of neuronal inhibition,” Nature Reviews Neuroscience, vol. 9, no. 5, pp. 331–343, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. C. N. Connolly, B. J. Krishek, B. J. McDonald, T. G. Smart, and S. J. Moss, “Assembly and cell surface expression of heteromeric and homomeric γ-aminobutyric acid type A receptors,” Journal of Biological Chemistry, vol. 271, no. 1, pp. 89–96, 1996. View at Google Scholar · View at Scopus
  15. I. Sarto-Jackson and W. Sieghart, “Assembly of GABAA receptors (Review),” Molecular Membrane Biology, vol. 25, no. 4, pp. 302–310, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. C. C. K. Chao, W. C. Yam, and S. Lin-Chao, “Coordinated induction of two unrelated glucose-regulated protein genes by a calcium ionophore: human BiP/GRP78 and GAPDH,” Biochemical and Biophysical Research Communications, vol. 171, no. 1, pp. 431–438, 1990. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Mori, Q. Wang, K. D. Danenberg, J. K. Pinski, and P. V. Danenberg, “Both β-actin and GAPDH are useful reference genes for normalization of quantitative RT-PCR in human FFPE tissue samples of prostate cancer,” Prostate, vol. 68, no. 14, pp. 1555–1560, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. X. M. Fu and B. T. Zhu, “Human pancreas-specific protein disulfide-isomerase (PDIp) can function as a chaperone independently of its enzymatic activity by forming stable complexes with denatured substrate proteins,” Biochemical Journal, vol. 429, no. 1, pp. 157–169, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. C. A. McClintick, C. S. Theisen, J. E. Ferns, E. E. Fibuch, and N. W. Seidler, “Isoflurane preconditioning involves upregulation of molecular chaperone genes,” Biochemical and Biophysical Research Communications, vol. 411, no. 2, pp. 387–392, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. E. J. Tisdale, F. Azizi, and C. R. Artalejo, “Rab2 utilizes glyceraldehyde-3-phosphate dehydrogenase and protein kinase Cι to associate with microtubules and to recruit dynein,” Journal of Biological Chemistry, vol. 284, no. 9, pp. 5876–5884, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. M. F. García-Mayoral, I. Rodríguez-Crespo, and M. Bruix, “Structural models of DYNLL1 with interacting partners: African swine fever virus protein p54 and postsynaptic scaffolding protein gephyrin,” FEBS Letters, vol. 585, no. 1, pp. 53–57, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. P. A. Leventis and S. Grinstein, “The distribution and function of phosphatidylserine in cellular membranes,” Annual Review of Biophysics, vol. 39, no. 1, pp. 407–427, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. M. R. Baker, S. K. Benton, C. S. Theisen, C. A. McClintick, E. E. Fibuch, and N. W. Seidler, “Isoflurane's effect on protein conformation as a proposed mechanism for preconditioning,” Biochemistry Research International, vol. 2011, Article ID 739712, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. H. Chen, R. Q. He, Y. Liu, Y. Liu, and Z. G. Xue, “Effect of human neuronal tau on denaturation and reactivation of rabbit muscle D-glyceraldehyde-3-phosphate dehydrogenase,” Biochemical Journal, vol. 351, no. 1, pp. 233–240, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. M. B. Najjar, M. Chikindas, and T. J. Montville, “Changes in Listeria monocytogenes membrane fluidity in response to temperature stress,” Applied and Environmental Microbiology, vol. 73, no. 20, pp. 6429–6435, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. S. N. Lee, L. Li, and Z. Zuo, “Glutamate transporter type 3 knockout mice have a decreased isoflurane requirement to induce loss of righting reflex,” Neuroscience, vol. 171, no. 3, pp. 788–793, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Guo, W. C. Au, M. Shakoury-Elizeh et al., “Phosphatidylserine is involved in the ferrichrome-induced plasma membrane trafficking of Arn1 in Saccharomyces cerevisiae,” Journal of Biological Chemistry, vol. 285, no. 50, pp. 39564–39573, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. P. N. Moynagh and D. C. Williams, “Stabilization of the peripheral-type benzodiazepine acceptor by specific phospholipids,” Biochemical Pharmacology, vol. 43, no. 9, pp. 1939–1945, 1992. View at Publisher · View at Google Scholar · View at Scopus
  29. B. C. Wise, A. Guidotti, and E. Costa, “Phosphorylation induces a decrease in the biological activity of the protein inhibitor (GABA-modulin) of γ-aminobutyric acid binding sites,” Proceedings of the National Academy of Sciences of the United States of America, vol. 80, no. 3 I, pp. 886–890, 1983. View at Google Scholar · View at Scopus
  30. N. W. Seidler, “GAPDH in Anesthesia,” Advances in Experimental Medicine and Biology, vol. 985, pp. 269–291, 2013. View at Google Scholar